BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 18416448)

  • 41. A two stage conditional power adaptive design adjusting for treatment by covariate interaction.
    Ayanlowo AO; Redden DT
    Contemp Clin Trials; 2008 May; 29(3):428-38. PubMed ID: 18053774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determining sample size and power in clinical trials: the forgotten essential.
    Grimes DA; Schulz KF
    Semin Reprod Endocrinol; 1996 May; 14(2):125-31. PubMed ID: 8796935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statistical power and estimation of the number of required subjects for a study based on the t-test: a surgeon's primer.
    Livingston EH; Cassidy L
    J Surg Res; 2005 Jun; 126(2):149-59. PubMed ID: 15919413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sample size calculations: basic principles and common pitfalls.
    Noordzij M; Tripepi G; Dekker FW; Zoccali C; Tanck MW; Jager KJ
    Nephrol Dial Transplant; 2010 May; 25(5):1388-93. PubMed ID: 20067907
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials.
    Tamura RN; Huang X
    Clin Trials; 2007; 4(4):309-17. PubMed ID: 17848492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sample sizes based on the log-rank statistic in complex clinical trials.
    Lakatos E
    Biometrics; 1988 Mar; 44(1):229-41. PubMed ID: 3358991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A small p-value from an observed data is not evidence of adequate power for future similar-sized studies: a cautionary note.
    Atenafu EG; Hamid JS; Stephens D; To T; Beyene J
    Contemp Clin Trials; 2009 Mar; 30(2):155-7. PubMed ID: 19063996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Roaming through methodology. XXXIII. Ethics of sample size estimation: less subjects needed for a one-sided than for a two-sided statistical investigation].
    Knottnerus JA; Bouter LM
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1051-4. PubMed ID: 11414165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A simple sample size formula for analysis of covariance in randomized clinical trials.
    Borm GF; Fransen J; Lemmens WA
    J Clin Epidemiol; 2007 Dec; 60(12):1234-8. PubMed ID: 17998077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Basic statistics for clinicians: 1. Hypothesis testing.
    Guyatt G; Jaeschke R; Heddle N; Cook D; Shannon H; Walter S
    CMAJ; 1995 Jan; 152(1):27-32. PubMed ID: 7804919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sample size determination in step-up testing procedures for multiple comparisons with a control.
    Kwong KS; Cheung SH; Wen MJ
    Stat Med; 2010 Nov; 29(26):2743-56. PubMed ID: 20799258
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple-arm superiority and non-inferiority designs with various endpoints.
    Chang M
    Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statistical power calculations.
    Lenth RV
    J Anim Sci; 2007 Mar; 85(13 Suppl):E24-9. PubMed ID: 17060421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The need for more efficient trial designs.
    Golub HL
    Stat Med; 2006 Oct; 25(19):3231-5; discussion 3313-4, 3326-47. PubMed ID: 16819752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sample size and statistical power in the small-animal analgesia literature.
    Hofmeister EH; King J; Read MR; Budsberg SC
    J Small Anim Pract; 2007 Feb; 48(2):76-9. PubMed ID: 17286659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Some design issues of strata-matched non-randomized studies with survival outcomes.
    Mazumdar M; Tu D; Zhou XK
    Stat Med; 2006 Dec; 25(23):3949-59. PubMed ID: 16596571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A flexible strategy for testing subgroups and overall population.
    Alosh M; Huque MF
    Stat Med; 2009 Jan; 28(1):3-23. PubMed ID: 18985704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Test equality and sample size calculation based on risk difference in a randomized clinical trial with noncompliance and missing outcomes.
    Lui KJ; Chang KC
    Biom J; 2008 Apr; 50(2):224-36. PubMed ID: 18264992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.